The challenges of implementing ADHD clinical guidelines and research best evidence in routine clinical care settings: Delphi survey and mixed-methods study

Article English OPEN
Hall, Charlotte L. ; Taylor, John A. ; Newell, Karen ; Baldwin, Laurence ; Sayal, Kapil ; Hollis, Chris (2016)
  • Publisher: The Royal College of Psychiatrists
  • Journal: BJPsych open, volume 2, issue 1, pages 25-31 (eissn: 2056-4724)
  • Related identifiers: pmc: PMC4995556, doi: 10.1192/bjpo.bp.115.002386
  • Subject: Paper
    mesheuropmc: behavioral disciplines and activities | health care economics and organizations | mental disorders

Background The landmark US Multimodal Treatment of ADHD (MTA) study established the benefits of individualised medication titration and optimisation strategies to improve short- to medium-term outcomes in attention-deficit hyperactivity disorder (ADHD). This individualised medication management approach was subsequently incorporated into the National Institute for Health and Care Excellence (NICE) ADHD Clinical Guidelines (NICE CG78). However, little is known about clinicians’ attitudes towards implementing these medication management strategies for ADHD in routine care. Aims To examine National Health Service (NHS) healthcare professionals’ consensus on ADHD medication management strategies. Method Using the Delphi method, we examined perceptions on the importance and feasibility of implementing 103 ADHD treatment statements from sources including the UK NICE ADHD guidelines and US medication management algorithms. Results Certain recommendations for ADHD medication management were judged as important and feasible to implement, including a stepwise titration of stimulant medication. Other recommendations were perceived as important but not feasible to implement in routine practice, such as weekly clinic follow-up with the family during titration and collection of follow-up symptom questionnaires. Conclusions Many of the key guideline recommendations for ADHD medication management are viewed by clinicians as important and feasible to implement. However, some recommendations present significant implementation challenges within the context of routine NHS clinical care in England. Declaration of interest C.H. and K.S. were members of the Guideline Development Group for the NICE ADHD Clinical Guideline (NICE CG78). Copyright and usage © 2016 The Royal College of Psychiatrists. This is an open access article distributed under the terms of the Creative Commons Non-Commercial, No Derivatives (CC BY-NC-ND) licence.
  • References (33)
    33 references, page 1 of 4

    1 Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, et al. Attentiondeficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000; 48: 9-20.

    2 Wilens TE, McDermott SP, Biederman J, Abrantes A, Hahsey A, Spencer TJ. Cognitive therapy in the treatment of adults with ADHD: a systematic chart review of 26 cases. J Cogn Psychother 1999; 13: 215-26.

    3 National Institute for Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. Clinical guideline 72. NICE, 2008.

    4 MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999; 56: 1073-86.

    5 Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001; 40: 168-79.

    6 Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, et al. Costeffectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry 2005; 162: 1628-36.

    7 Pliszka SR, Greenhill LL, Crismon ML, Sedillo A, Carlson C, Conners CK, et al. The Texas Children's Medication Algorithm Project: report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I. Attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2000; 39: 908-19.

    8 Pliszka SR, Lopez M, Crismon ML, Toprac MG, Hughes CW, Emslie GJ, et al. A feasibility study of the Children's Medication Algorithm Project (CMAP) algorithm for the treatment of ADHD. J Am Acad Child Adolesc Psychiatry 2003; 42: 279-87.

    9 Sheldon T, Cullum N, Dawson D, Lankshear A, Lowson K, Watt I, et al. What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ 2004; 329: 999.

    10 Atkinson M, Hollis C. NICE guideline: attention deficit hyperactivity disorder. Arch Dis Child Educ Pract Ed 2010; 95: 24-7.

  • Metrics
    No metrics available
Share - Bookmark